Cardinal acquires Gala for $15.5 million

Cardinal Health (CAH) will purchase the 42% of gene insertion company Gala Biotech (Middleton, Wis.) it does not already own for $15.5 million in cash. Since 2002, CAH has invested $12 million in Gala...